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Edited by Richard MaraisAbstract Phosphoinoisitide dependent kinase l (PDK1) is pro-
posed to phosphorylate a key threonine residue within the cata-
lytic domain of the protein kinase C (PKC) superfamily that
controls the stability and catalytic competence of these kinases.
Hence, in PDK1-null embryonic stem cells intracellular levels of
PKCa, PKCb1, PKCc, and PKCe are strikingly reduced.
Although PDK1-null cells have reduced endogenous PKC levels
they are not completely devoid of PKCs and the integrity of
downstream PKC eﬀector pathways in the absence of PDK1
has not been determined. In the present report, the PDK1
requirement for controlling the phosphorylation and activity of
a well characterised substrate for PKCs, the serine kinase pro-
tein kinase D, has been examined. The data show that in embry-
onic stem cells and thymocytes loss of PDK1 does not prevent
PKC-mediated phosphorylation and activation of protein kinase
D. These results reveal that loss of PDK1 does not functionally
inactivate all PKC-mediated signal transduction.
 2007 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Open access under CC BY license.1. Introduction
Phosphoinoisitide dependent kinase l (PDK1) phosphory-
lates a key threonine residue within the catalytic domain of a
number of AGC family kinases, including diacylglycerol-regu-
lated kinases of the protein kinase C (PKC) superfamily and
phosphatidyl inositol-3 kinase (PI3K)-controlled serine kinases
such as Akt/PKB and the 70-kilodalton ribosomal S6 kinase 1
(S6K1) [1]. PDK1-mediated phosphorylation of many of these
AGC kinases is essential for their activation. Accordingly,
deletion of PDK1 by homologous recombination removes
one of the rate-limiting regulators of multiple serine kinasesAbbreviations: ES cell, embryonic stem cell; p90RSK, p90 ribosomal
S6 kinase; PDK1, 30-phosphoinositide-dependent protein kinase-1;
PKC, protein kinase C; PKD, protein kinase D; S6K1, 70-kilodalton
ribosomal S6 kinase 1
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death and explore the role of PDK1 in diﬀerent tissues, mice
expressing PDK1 alleles ﬂanked with the loxP Cre excision se-
quence (PDK1ﬂDneo/ﬂDneo mice) have been generated. These
were ﬁrst used to achieve muscle speciﬁc deletion of PDK1,
producing mice that die early with severe defects in cardiac
function [3]. The importance of PDK1 for T lymphocyte biol-
ogy has also been explored by looking at T cell development
following T lineage speciﬁc deletion of PDK1. These studies
showed that deletion of PDK1 in T cell progenitors in the thy-
mus results in a block in T cell diﬀerentiation, indicating that
PDK1 has essential functions in T lymphocyte development
[4].
The importance of PDK1 for T cell development in the
thymus focuses attention on the identiﬁcation of the PDK1
substrates directly involved in mediating the unique and non-
redundant functions of this kinase in vivo. In this context,
studies of mouse embryonic stem cells in which both PDK1 al-
leles have been deleted have shown that PDK1 is necessary for
T-loop phosphorylation, and catalytic activity, of the AGC ki-
nases Akt/PKB, S6K1 and p90 ribosomal S6 kinase (p90RSK)
[5]. However, PDK1 is not required for the phosphorylation
and activation of other AGC kinases such as PKA or AMPK
[5].
One very important subfamily of AGC kinases that can be
regulated by PDK1 are the protein kinase C enzymes. There
are multiple isoforms of PKC: the classical PKCs (a, bI, bII
and c) which are regulated by calcium, diacylglycerol (DAG)
and phospholipids; novel PKCs (d, e, g and h) which are reg-
ulated by DAG and phospholipids; and the atypical PKCs (f
and k) which are insensitive to both calcium and DAG. The
catalytic domain of PKCs have a conserved T-loop motif that
is a substrate for PDK1, and it has been proposed that PDK1
is responsible for T-loop phosphorylation of the various PKC
isoforms [6–8]. PDK1-mediated T-loop phosphorylation of
PKCs is proposed to stabilize protein expression by acting as
a priming signal that enables PKCs to achieve catalytic matu-
rity [6,7]. Here, PDK1 docks to a hydrophobic motif in the C-
terminus of newly synthesised PKC enzymes, enabling it to
phosphorylate their T-loop sites. Following T-loop phosphor-
ylation, PDK1 disengages enabling PKCs to autophosphory-
late their C-terminal hydrophobic motifs and achieve
catalytic maturity [9–11]. Once mature, PKCs remain inactive
due to autoinhibition from their pseudosubstrate motifs and
are only activated following the generation of second messen-
gers, such as diacylglycerol and calcium.European Biochemical Societies. Open access under CC BY license.
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PDK1 is responsible for controlling the amount of mature/cat-
alytically competent PKCs expressed in cells [11]. Hence, in the
absence of PDK1, intracellular levels of PKCa, PKCb1,
PKCc, and PKCe are strikingly reduced [6,12]. PKCn levels
are similar in wild-type and PDK1-null embryonic stem cell
(ES cells) although PKCn is not phosphorylated on its T-loop
Thr410 site in the absence of PDK1 [6,13]. PKCd expression is
also reduced in PDK1-null cells [6,12] although there was still
phosphorylation of the PKCd T-loop site Thr505 in the resid-
ual pool of PKCd still present in PDK1-null cells [13]. More-
over, there is some evidence in the literature that T-loop
phosphorylation is not absolutely critical for PKCd catalytic
activity, since a bacterially-expressed Thr505A PKCd mutant
protein retains some activity in vitro [14]. Of note, a glutamic
acid residue at position 500 within the PKCd activation loop,
which is important for catalytic activity [15], could potentially
compensate for the lack of PKCd T-loop phosphorylation in
PDK1-null cells.
These studies support the hypothesis that PDK1 has an
important role in regulating PKC phosphorylation and stabil-
ity. However, it has not been shown unequivocally that the re-
duced levels of PKCs in PDK1-null cells abrogate PKC-
mediated cellular responses. In this context, it has been shown
that in the absence of PDK1 there is loss of Akt/PKB and
S6K1 T-loop phosphorylation and a corresponding inability
of cells to regulate phosphorylation of Akt/PKB or S6K1 sub-
strates [5]. There is thus conﬁdence that Akt/PKB and S6K1
function is defective in PDK1-null cells. This has not been
determined for the PKCs because although PDK1-null cells
have reduced endogenous PKC levels the integrity of down-
stream PKC eﬀector pathways in PDK1-null cells has not been
determined.
One well characterised target for novel PKCs is the serine ki-
nase protein kinase D (PKD). Activation of PKD requires the
phosphorylation of two key serine residues within the catalytic
domain [16,17]. These residues are absolutely conserved
through evolution from C. elegans to man and are substrates
for novel PKCs. The activation of PKCs is thus required for
PKD activation in a variety of cell lineages in response to aFig. 1. PKD activity in PKD1-null pre-T cells. DN4 thymocytes, puriﬁed from
were left unstimulated () or were treated with PdBu (20 ng/ml) for 10 m
indicated) were separated by SDS–PAGE and analyzed by Western blottin
phospho-speciﬁc antibody against its Ser916 autophosphorylation site.number of diﬀerent stimuli [16,17]. For example, it has been
demonstrated that PKD activity in lymphocytes is regulated
by PKC-mediated phosphorylation of its catalytic domain
[18,19] and phosphorylation of the PKD catalytic domain is
reduced in PKCb-deﬁcient spleenocytes [20]. It would there-
fore be expected that PKD would remain inactive if PKCs can-
not achieve catalytic maturity in PDK1-null cells. In support
of this hypothesis, previous work has established that co-
expression of PDK1 and the novel PKCe isoform, together
with PKD, enhances PKD activity [21]. The hypothesis that
PKD activation is dependent on PDK1 has not been fully
investigated and is important to address as it is one way to as-
sess whether there is residual functional PKC activity in
PDK1-null cells. Accordingly, the objective of the present
study was to examine whether loss of PDK1 results in loss
of the PKC signalling pathway that regulates PKD.2. Results and discussion
2.1. Activation of protein kinase D in PDK1/ thymocytes
To investigate the impact of PDK1 loss on protein kinase D
activation in PDK1 deﬁcient T lymphocytes, mice expressing
PDK1 alleles ﬂanked with the loxP Cre excision sequence
(PDK1ﬂDneo/ﬂDneo) were bred with transgenic mice expressing
Cre recombinase under the control of the proximal p56lck pro-
moter which induces expression of Cre in T cell progenitors in
the thymus. It has been shown previously that in Lck-
Cre+PDK1ﬂDneo/ﬂDneo mice PDK1 is deleted in pre-T cells, pre-
venting normal T cell development [4]. To explore the role of
PDK1 in the regulation of PKD activity, wild-type or
PDK1/ pre-T cells were isolated and left unstimulated, stim-
ulated with a crosslinking a-CD3 antibody (to activate
preTCR signalling) or were stimulated with the phorbol ester
PdBu (a diacylglycerol mimetic which activates classical/novel
PKCs), as indicated. PKD catalytic activity was monitored
using an antisera that recognises PKD molecules that are auto-
phosphorylated on Ser916 [22]. The data (Fig. 1) show that in
quiescent wild-type thymocytes PKD is not autophosphory-
lated on Ser916 whereas a-CD3 or PdBu stimulation stronglywild-type (PDK1+/+) and LckCre+PKD1ﬂDneo/ﬂDneo (PKD1/) mice,
in before lysis. Protein extracts from 1 · 106 cells (unless otherwise
g with the indicated antibodies. PKD activity was assessed using a
Fig. 2. PKD activity in PKD1-null embryonic stem cells. (A) Serum-
starved wild-type (PKD1+/+) and PKD1/ murine ES cells were left
unstimulated () or were treated with PdBu (20 ng/ml) or serum (10%)
for 10 min before lysis. Protein extracts were separated by SDS–PAGE
and analyzed by Western blotting with the indicated antibodies. (B)
Serum starved wild-type and PKD1/ murine ES cells were left
unstimulated () or were treated with/without serum (10%) for varying
times before lysis. Protein extracts (200 lg) were separated by SDS–
PAGE and analyzed by Western blotting with the indicated antibodies.
(C) Protein extracts (200–12 lg) from wild-type and PKD1/ murine
ES cells were separated by SDS–PAGE and analyzed by Western
blotting with a pThr505 PKCd antibody.
Fig. 3. PKD activity in PKD1-null ES cells is sensitive to the PKC
inhibitor, GF109203X. Wild-type and PKD1/ murine ES cells were
pretreated with 5 lM GF109203X (GF) for 20 min, then left unstim-
ulated () or were treated with PdBu (20 ng/ml) for 10 min before
lysis. Protein extracts (200 lg) were separated by SDS–PAGE and
analyzed by Western blotting with the indicated antibodies.
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autophosphorylation. The results also show that both a-CD3
and PdBu treatment induce strong PKD Ser916 autophospho-
rylation in PDK1/ pre-T cells (Fig. 1). PKD activation is
dependent on PKC-mediated phosphorylation of two key ser-
ine residues (Ser744/S748) within the PKD catalytic domain
and as shown in Fig. 1, PKD is phosphorylated on Ser744/
S748 following a-CD3 or PdBu activation in both wild-type
and PDK1/ pre-T cells.
The phosphorylation and activation of PKD in PDK1/
pre-T cells argues that these cells still contain a functional, cat-
alytically competent PKC(s) that is able to respond to diacyl-
glycerol/phorbol ester signals. RNAi experiments have
demonstrated that PKCe in Swiss 3T3 cells or PKCd in HeLa
cells are the PKC isoforms responsible for serine phosphoryla-
tion (Ser744/S748) within the PKD activation loop [23,24].
PKCd has been shown to be residually phosphorylated on its
T-loop Thr505 site in PDK1-null ES cells [13]. We therefore
examined the phosphorylation status of the PKCd T-loop site,
Thr505, in PDK1/ pre-T cells. The data in Fig. 1 show basal
phosphorylation of PKCd Thr505 in wild-type pre-T cells and
also show that signiﬁcant phosphorylation of PKCd on Thr505
in retained in PDK1/ pre-T cells. In contrast, as previously
demonstrated, PDK1/ pre-T cells have lost activity of the
PKB/S6K1 signalling pathway that controls the phosphoryla-
tion of the ribosomal S6 subunit on Ser235/236 [4,25]. The
data in Fig. 1 also explore the impact of PDK1 loss on the
T-loop phosphorylation of p90RSK1 and PRK1. The data
show Western blot analysis of wild type and PDK1 null pre-
T cells with a phospho-speciﬁc antibody against Ser227 in
p90RSK1 and show that this site is basally phosphorylated
in wild-type pre-T cells but is not phosphorylated in PDK1-
null pre-T cells. Similarly, basal phosphorylation of PRK1
on its Thr774 T-loop site is substantially reduced in PDK1-null
pre-T cells. Thus, PDK1-null pre-T cells show defective activa-
tion of some, but not all, AGC family kinases: regulation of a
PKC–PKD signalling pathway remains intact in these cells.
2.2. Activation of protein kinase D in PDK1/ ES cells
The experiments in Fig. 1 show that PDK1 is not essential
for PKD activation in thymocytes. To probe further the
involvement of PDK1 in the regulation of PKC–PKD signal-
ling, experiments in wild-type and PDK1/ mouse embryonic
stem cells were performed. Western blot analysis of wild-type
and PDK1/ ES cells with a PKCd Thr505 phosphospeciﬁc
antisera conﬁrm that PKCd Thr505 phosphorylation is detect-
able, albeit slightly reduced, in PDK1-null versus wild-type ES
cells (Fig. 2A–C). To probe PKD activity, cells were left
unstimulated or activated by exposure to serum or phorbol es-
ter as indicated and PKD catalytic activity monitored using
the pSer916 antisera. In quiescent, wild-type ES cells, PKD
was not autophosphorylated on Ser916 but both serum and
PdBu stimulation strongly and rapidly induced PKD activity
as measured by increased Ser916 autophosphorylation
(Fig. 2A and B). Serum or PdBu stimulation also induced
PKD activity in the PDK1/ ES cells (Fig. 2A and B) whereas
p90RSK1 T-loop phosphorylation (Ser227) was basally detect-
able in wild-type ES cells but not in the PDK1/ ES cells
(Fig. 3). S6K1 signalling was also abrogated, as expected, in
the PDK1/ ES cells, as shown by the lack of phosphoryla-
tion of its substrate, the S6 ribosomal protein subunit
(Fig. 2B).
The ability of serum and phorbol esters to activate PKD in
PDK1-null ES cells is an indication that there is residual,
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vation of PKD can be prevented by the PKC inhibitor
GF109203X [17]. Therefore, the eﬀects of GF109203X, on
PKD activation in wild-type or PDK1/ ES cells was exam-
ined. The data (Fig. 3) show that PKD was phosphorylated
on Ser916 in activated PDK1+/+ and PDK1/ cells but that
PKD autophosphorylation on Ser916 was prevented by prior
treatment of both cell types with GF109203X.3. Concluding remarks
Loss of PDK1 in ES cells causes a reduction in levels of
PKCa, bI, c, d, and e [6,12] but it was not resolved whether
the residual PKC in these cells is functional. As discussed
above, there is a large body of evidence that PKD activation
is mediated by novel PKCs such as PKCd and e and it has pre-
viously been proposed that PDK1 is required for activation of
PKD [21], reﬂecting the requirement of PDK1 for phosphory-
lation of the key priming T-loop phosphorylation sites in
PKCs. However, the present study shows that the hypothesis
that PKD activation is dependent on PDK1 is incorrect. The
reason this model fails is that there is not a complete loss of
PKC activity in the absence of PDK1. We show that in
PDK1-null pre-T cells PKCd is still phosphorylated on its T-
loop site Thr505; hence activation of pre-T cells with phorbol
esters can still induce phosphorylation of PKD on its PKC
substrate sequences Ser744/S748, inducing PKD activation
and subsequent autophosphorylation on Ser916. In addition,
the present data show that PKD can also be activated by phor-
bol esters or serum stimulation of PDK1-null ES cells in a
PKC-regulated manner. Thus, the present results showing acti-
vation of PKD in PDK1/ cells is evidence that at least one
PKC-mediated signalling pathway is intact in the absence of
PDK1.
While loss of PDK1 does not prevent the activation of PKD,
the issue of whether the eﬃciency of PKD activation is aﬀected
in PDK1-null cells requires further experimentation. While ro-
bust activation of PKD signalling is observed in PDK1-null ES
cells and pre-T cells in response to phorbol esters or CD3
crosslinking we cannot exclude the possibility that PKD acti-
vation may be compromised in PDK1-null mature peripheral
T cells during physiological peptide:MHC stimulation, how-
ever these experiments await the development of genetic mod-
els to test this.
In summary, PDK1 is essential for pre-T cell development
and its loss is associated with loss of PKB/S6K1-mediated sig-
nal transduction [4,25]. The present results now show loss of
p90RSK and PRK1 T-loop phosphorylation in PDK1/
pre-T cells but reveal that the PKCd T-loop site Thr505 is still
phosphorylated in PDK1-null pre-T cells. It has been proposed
that the Thr505 T-loop site in PKCd (as well as the corre-
sponding T-loop site in PKCh, [26]) can be autophosphory-
lated, which may explain why PKCd Thr505 is still
phosphorylated in the PDK1-null cells. Alternatively the pres-
ent results could argue for the existence of another PKCd
priming kinase in developing thymocytes. Whatever the molec-
ular basis for the continued phosphorylation of PKCd follow-
ing the loss of PDK1, the present results show that there is still
residual functional PKC activity once PDK1 is lost. Hence, the
importance of PDK1 for T cell development must reﬂect therequirement for PDK1 mediated phosphorylation of other
members of the AGC serine kinase family, such as Akt/PKB,
S6K1 or p90RSK, since phosphorylation and activity of these
kinases is strictly dependent on PDK1 expression.4. Materials and methods
4.1. Cell preparation and stimulation
PDK1+/+ and PDK1/ murine embryonic stem cells [5] were grown
on gelatinised tissue culture plates in Knockout DMEM supplemented
with 10% knockout serum replacement, 15% foetal bovine serum (Hy-
clone), 0.1 mM non-essential amino acids, antibiotics (100 U/ml peni-
cillin G, 100 lg/ml streptomycin and 1 lg/ml ciproﬂoxacin [Bayer
Pharmaceuticals]), 2 mM L-glutamine, 1 mM sodium pyruvate,
0.1 mM b-mercaptoethanol and 25 ng/ml murine leukaemia inhibitory
factor (LIF).
4.2. Mice
All mice used were between 5 and 7 weeks of age. Mice were bred
and maintained in speciﬁc pathogen-free conditions and animal exper-
imentation was approved by Home Oﬃce project license PPL60/3116.
T-PDK1/ mice were generated by crossing mice with PDK1 ﬂoxed
alleles (PDK1ﬂDneo/ﬂDneo) with mice expressing Cre recombinase under
the control of the p56lck promoter to ablate expression of PDK1 in T
cells [2,4]. Control mice used for analyses of T-PDK1/ mice were
age-matched phenotypically normal littermates.
4.3. Puriﬁcation of thymocyte subpopulations
Antibodies conjugated to ﬂuorescein isothiocyanate (FITC), phyco-
erythrin (PE), allophycocyanin (APC) and biotin were obtained from
PharMingen. Cells were stained for surface expression of the following
markers: CD4, CD8, CD25, CD44, CD3e, cd, B220, and Thy1. The
DN4 subpopulation were deﬁned by their cell surface marker expres-
sion and subsequently sorted using a Vantage cell sorter (Becton Dick-
inson) or AutoMacs magnetic cell sorter (Miltenyi Biotec).
4.4. Cell lysis and Western blot analysis
Cells were lysed for 10 min at 4 C (20 · 106 cells/ml) using buﬀer:
100 mM HEPES, pH 7.4, 150 mM NaCl, 1% NP40, 20 mM sodium
ﬂuoride, 20 mM iodoacetamide, 2 lM EDTA, 1 mM sodium ortho-
vanadate, 2 lg/ml pepstatin A, 2 lg/ml leupeptin, 2 lg/ml chymostatin,
2 lg/ml antipain, 40 mM b-glycerophosphate and 1 mM phen-
ylmethylsulfonylﬂouride. Soluble proteins were concentrated by pre-
cipitation with 1.5 vol. of acetone and separated by 8% sodium
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE),
transferred to polyvinylidene diﬂuoride membranes and detected by
Western blot analysis with the indicated antibodies (Cell Signalling
Technology).
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